AXDX

Stats

Summary

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

Market Cap: 16 Million

Primary Exchange: NASDAQ

Website: http://acceleratediagnostics.com/

Shares Outstanding: 14.6 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.3991889759541653

Sector: Manufacturing

Industry: Analytical Laboratory Instrument Manufacturing

Ethical Flags

Longest drawdown: 2724 trading days

From: 2014-06-23 To: 2024-03-07

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor